S K Spangler

Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers

Peter C. Appelbaum, S K Spangler, Michael R. Jacobs · Antimicrobial Agents and Chemotherapy · 1990 · 172 citations · Full text

Antimicrobial Susceptibility, Health Sciences, Antibiotics +13

Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes

S K Spangler, Michael R. Jacobs, Peter C. Appelbaum · Antimicrobial Agents and Chemotherapy · 1994 · 104 citations · Full text

Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin

S K Spangler, Michael R. Jacobs, Peter C. Appelbaum · Antimicrobial Agents and Chemotherapy · 1992 · 88 citations · Full text

Antimicrobial Chemotherapy, Antibiotic Resistance, Drug Resistance +18

Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes

Peter C. Appelbaum, M R Jacobs, S K Spangler et al. · Antimicrobial Agents and Chemotherapy · 1986 · 84 citations

Beta-lactamase Inhibitors, Beta-lactamase-producing Anaerobes, Comparative Activity +15

Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin

S K Spangler, Michael R. Jacobs, Peter C. Appelbaum · Antimicrobial Agents and Chemotherapy · 1994 · 79 citations · Full text